Atlas Trials

Heplisav-B Revaccination for Hepatitis B Vaccine Nonresponders

Clinical trial NCT05791851 · COMPLETED

Trial details

NCT number
NCT05791851
Sponsor
University of Maryland, Baltimore
Status
COMPLETED
Study type
OBSERVATIONAL
HIV InfectionsHepatitis BVaccine Response Impaired
Start date
2019-10-23
Primary completion
2022-06-14
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.